Mercy moves more facilities to Fore River site, including surgery center

The hospital is on track to move all of its functions to the new site by the end of the year.

Types of sedation: How to chill out in the dentist’s chair

MaineGeneral Health working on contingency plan for staffing as deadline approaches for Mills’ vaccination mandate

As of Tuesday, about 81% of the hospital's employees met the COVID-19 vaccination mandate Gov. Janet Mills has set for health care workers.

Few Maine hospitals comply with federal price disclosure law

Most hospitals have yet to publish information that shows charges negotiated with insurance companies or what an uninsured patient would pay for a service.

Most Maine health plans no longer waive patient costs for COVID-19 treatment

Only one major insurer, Community Health Options, is bucking the national trend and waiving cost-sharing for COVID-19 patients through the end of the year.

Patient says some MaineGeneral staff threatened to not treat her for asking if they were vaccinated

MaineGeneral spokesperson Joy McKenna said nothing prohibits patients from asking about staff members' vaccination status and the hospital would not refuse treatment for such queries.

Health care workers protest vaccine mandate in Augusta

Nearly 400 people, many in scrubs, lined both sides of State Street in front of the Maine State House to protest the requirement to be fully vaccinated by Oct. 1 or have a medical exemption.

30 Maine school districts join suit against opioid manufacturer Purdue Pharma

At least 30 Maine school districts have joined a class-action lawsuit against opioid manufacturer Purdue Pharma for damages related to the opioid crisis.

COVID-19 delta variant puts western and central Maine towns at risk

Public health officials have warned that the highly contagious strain of the disease could be a danger to unvaccinated populations, while emphasizing the vaccines' effectiveness in protecting against COVID-19.

Controversial new Alzheimer’s drug gives patients in Maine hope

The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.